These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 3680555)
41. Electrophysiologic and hemodynamic effects of a single oral dose of pilsicainide hydrochloride, a new class 1c antiarrhythmic agent. Ino T; Atarashi H; Kuruma A; Onodera T; Saitoh H; Hayakawa H J Cardiovasc Pharmacol; 1998 Jan; 31(1):157-64. PubMed ID: 9456290 [TBL] [Abstract][Full Text] [Related]
42. Electrophysiologic effects of oral propafenone in Wolff-Parkinson-White syndrome studied by programmed electrical stimulation. Sethi KK; Prasad GS; Mohan JC; Arora R; Khalilullah M Indian Heart J; 1991; 43(1):5-10. PubMed ID: 1894303 [TBL] [Abstract][Full Text] [Related]
43. Propafenone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in the treatment of arrhythmias. Harron DW; Brogden RN Drugs; 1987 Dec; 34(6):617-47. PubMed ID: 3322781 [TBL] [Abstract][Full Text] [Related]
44. [Hemodynamic and electrophysiologic effects of the new calcium antagonist Ro 11-1781 (author's transl)]. Bödeker K; Bischoff KO; Menken U; Hager W Z Kardiol; 1980 Nov; 69(11):790-6. PubMed ID: 7467662 [TBL] [Abstract][Full Text] [Related]
45. Limited role of intravenous propafenone hydrochloride in the treatment of sustained ventricular tachycardia: electrophysiologic effects and results of programmed ventricular stimulation. Doherty JU; Waxman HL; Kienzle MG; Cassidy DM; Marchlinski FE; Buxton AE; Josephson ME J Am Coll Cardiol; 1984 Aug; 4(2):378-81. PubMed ID: 6736479 [TBL] [Abstract][Full Text] [Related]
47. New antiarrhythmic drugs in pediatric use: propafenone. Paul T; Janousek J Pediatr Cardiol; 1994; 15(4):190-7. PubMed ID: 7991437 [TBL] [Abstract][Full Text] [Related]
48. Effect of propafenone in the Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term follow-up. Breithardt G; Borggrefe M; Wiebringhaus E; Seipel L Am J Cardiol; 1984 Nov; 54(9):29D-39D. PubMed ID: 6496367 [TBL] [Abstract][Full Text] [Related]
49. Epicardial, endocardial and transmural mapping in assessing electrophysiological effects of 14-C lidocaine and 14-C propafenone on activation times in experimental chronic myocardial infarction. Correlations with myocardial drugs concentrations. Naccarella FF; Agarwal JB; Weintraub WS; Bracchetti D; Helfant RH G Ital Cardiol; 1984 Oct; 14(10):825-9. PubMed ID: 6519392 [TBL] [Abstract][Full Text] [Related]
50. [Propafenone--a promising anti-arrhythmia agent?]. Rozsíval V Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1990; 33(4):359-63. PubMed ID: 2130480 [TBL] [Abstract][Full Text] [Related]
51. Are there stereoselective electrophysiologic effects of intravenously administered (S)- or (R)-propafenone hydrochloride in patients with supraventricular tachycardia? Candinas R; Gloor HO; Lindner W; Ha HR; Buchinger W; Amann FW; Follath F Eur J Clin Pharmacol; 1996; 50(3):185-90. PubMed ID: 8737757 [TBL] [Abstract][Full Text] [Related]
52. Efficacy of ajmaline and propafenone in patients with accessory pathways: a prospective randomized study. Chen X; Borggrefe M; Martinez-Rubio A; Hief C; Haverkamp W; Hindricks G; Breithardt G J Cardiovasc Pharmacol; 1994 Oct; 24(4):664-9. PubMed ID: 7528850 [TBL] [Abstract][Full Text] [Related]
53. Effects of pilsicainide on systemic hemodynamics and cardiac function of anesthetized dogs. Sakanashi M; Noguchi K; Matsuzaki T; Ojiri Y; Nakasone J; Itomine T; Higuchi M; Shiroma N Cardioscience; 1993 Dec; 4(4):241-50. PubMed ID: 8298065 [TBL] [Abstract][Full Text] [Related]